CD82 and neoplasm: Tspan8 was originally identified as a tumor-associated antigen by an antibody (CO-029) (8), CD63 by a melanoma-associated antigen (ME491) (9), CD151 was re-identified by an antimetastatic antibody (10), and CD82/KAI1 as a metastasis suppressor gene (11).